APA (7th ed.) Citation

Nag, K., Sarker, M. E. H., Kumar, S., Khan, H., Chakraborty, S., Islam, M. J., . . . Sultana, N. (2022). DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine/drug delivery. Scientific Reports, 12(1), 1. https://doi.org/10.1038/s41598-022-12100-z

Chicago Style (17th ed.) Citation

Nag, Kakon, et al. "DoE-derived Continuous and Robust Process for Manufacturing of Pharmaceutical-grade Wide-range LNPs for RNA-vaccine/drug Delivery." Scientific Reports 12, no. 1 (2022): 1. https://doi.org/10.1038/s41598-022-12100-z.

MLA (9th ed.) Citation

Nag, Kakon, et al. "DoE-derived Continuous and Robust Process for Manufacturing of Pharmaceutical-grade Wide-range LNPs for RNA-vaccine/drug Delivery." Scientific Reports, vol. 12, no. 1, 2022, p. 1, https://doi.org/10.1038/s41598-022-12100-z.